Insights

Regulatory Expertise The Paul-Ehrlich-Institut possesses extensive experience in regulatory tasks related to vaccines and biomedicines, making it a valuable partner for pharmaceutical companies seeking approval, safety evaluation, and post-market surveillance in Germany and internationally.

Research and Innovation With a strong emphasis on experimental research in biomedicine and life sciences, the institute offers opportunities for collaboration on cutting-edge vaccine development, biomedicines, and innovative medical technologies.

International Collaborations The institute actively partners with global organizations such as CEPI, WAHO, and the WHO, providing a gateway for businesses interested in expanding into European markets or engaging in international health initiatives and epidemic preparedness projects.

Public Sector Engagement As an agency under the German Federal Ministry of Health, the institute offers avenues for public health collaborations, government contracts, and funding opportunities targeting vaccine safety, pharmacovigilance, and health policy initiatives.

Market Focus The institute's focus on vaccines and biomedicines for both human and veterinary use presents sales opportunities for suppliers of pharmaceutical testing services, scientific advisory tools, and quality assurance solutions tailored to life sciences regulatory compliance.

Similar companies to Paul-Ehrlich-Institut

Paul-Ehrlich-Institut Tech Stack

Paul-Ehrlich-Institut uses 8 technology products and services including SAP FICO, Cart Functionality, SAP Financial Accounting, and more. Explore Paul-Ehrlich-Institut's tech stack below.

  • SAP FICO
    Accounting
  • Cart Functionality
    E-commerce
  • SAP Financial Accounting
    Enterprise Resource Planning
  • RequireJS
    Javascript Frameworks
  • Microsoft Word
    Office Suites
  • HSTS
    Security
  • Piwik PRO Core
    Web Analytics
  • Apache HTTP Server
    Web Servers

Paul-Ehrlich-Institut's Email Address Formats

Paul-Ehrlich-Institut uses at least 1 format(s):
Paul-Ehrlich-Institut Email FormatsExamplePercentage
First.Last@pei.deJohn.Doe@pei.de
83%
Last.First@pei.deDoe.John@pei.de
7%
FLast@pei.deJDoe@pei.de
6%
First_Last@pei.deJohn_Doe@pei.de
4%

Frequently Asked Questions

Where is Paul-Ehrlich-Institut's headquarters located?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's main headquarters is located at 51-59 Paul-ehrlich-street Dreieich, Hesse 63303 Germany. The company has employees across 2 continents, including EuropeNorth America.

What is Paul-Ehrlich-Institut's official website and social media links?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's official website is pei.de and has social profiles on LinkedIn.

What is Paul-Ehrlich-Institut's NAICS code?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Paul-Ehrlich-Institut have currently?

Minus sign iconPlus sign icon
As of May 2026, Paul-Ehrlich-Institut has approximately 450 employees across 2 continents, including EuropeNorth America. Key team members include President: S. V.Head Of Media And Public Relations: C. L.Head Of Fog3 "host-Pathogen Interactions": R. K.. Explore Paul-Ehrlich-Institut's employee directory with LeadIQ.

What industry does Paul-Ehrlich-Institut belong to?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut operates in the Research Services industry.

What technology does Paul-Ehrlich-Institut use?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's tech stack includes SAP FICOCart FunctionalitySAP Financial AccountingRequireJSMicrosoft WordHSTSPiwik PRO CoreApache HTTP Server.

What is Paul-Ehrlich-Institut's email format?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's email format typically follows the pattern of First.Last@pei.de. Find more Paul-Ehrlich-Institut email formats with LeadIQ.
Paul-Ehrlich-Institut logo

Paul-Ehrlich-Institut

Research ServicesHesse, Germany201-500 Employees

The Paul-Ehrlich-Institut is Germany’s Federal Institute for Vaccines and Biomedicines, combining regulatory responsibilities with active biomedical research. Based near Frankfurt in Langen, it operates under the Federal Ministry of Health and conducts research on biomedicines for humans and veterinary immunological products while also granting authorisations when benefits outweigh risks. The institute oversees clinical trial approvals, pharmacovigilance, official batch testing, scientific advice, and inspections, supporting public health through rigorous evaluation and monitoring of medicinal products. In addition to its regulatory duties, it engages in independent experimental research that informs and underpins its regulatory activities, aiming to improve access to safe, effective, and high-quality biomedicines. The organization collaborates with international bodies and contributes expert guidance to entities such as the WHO, EMA, and the European Commission, reflecting its dual role in science and regulation. A recent collaboration highlighted its ongoing international engagement, exemplified by partnerships and joint projects with global health organizations. The institute employs staff across its research and regulatory functions, reflecting its broad scope and public health mandate. } ) } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

Headquarters
51-59 Paul-ehrlich-street Dreieich, Hesse 63303 Germany
Website
pei.de
NAICS Code
5417 - Scientific Research and Development Services
Employees
201-500

Section iconFunding & Financials

  • $25M$50M

    Paul-Ehrlich-Institut's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Paul-Ehrlich-Institut's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.